Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Kazutaka Saito

Professor and Chair

Jichi Medical University Saitama Medical Center

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan

About

Kazutaka Saito is a Professor and Chair at Dokkyo Medical University Saitama Medical Center in Japan. His research primarily focuses on prostate cancer treatment, particularly through robot-assisted surgical techniques, as evidenced by his recent publications on urinary continence outcomes, neoadjuvant chemohormonal therapy, and prognostic factors related to prostate cancer and advanced renal cell carcinoma. Additionally, he explores the implications of surgical innovations and postoperative outcomes within the field.

Articles (18)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Kouhei Nishikawa

Associate professor

Mie University Graduate School of Medicine

JAPAN

View details

Hajime Tanaka

Assistant Professor

Tokyo Medical and Dental University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kazutaka Saito

Research Interests

Make your next move.

Explore related searches

About

Articles (18)

Early and late urinary continence outcomes after unilateral and bilateral nerve-sparing robot-assisted radical prostatectomy: A retrospective multicentre cohort study in Japan (the MSUG94 group)

Efficacy and safety of neoadjuvant chemohormonal therapy for high-risk prostate cancer treated with robot-assisted laparoscopic radical prostatectomy: a propensity score-matched analysis (the MSUG94 group)

Impact of Mannitol Administration on Postoperative Renal Function After Robot-Assisted Partial Nephrectomy

Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy: a retrospective multicenter cohort study in Japan (the MSUG94 group)

Prognostic Importance of Lymphovascular Invasion for Specific Subgroup of Patients with Prostate Cancer After Robot-Assisted Radical Prostatectomy (The MSUG94 Group)

Prognostic factors among patients with pathological Grade Group 5 prostate cancer based on robot-associated radical prostatectomy specimens from a large Japanese cohort (MSUG94)

Prognostic factors for high sperm DNA fragmentation in infertile Japanese men

Prognostic significance of inflammatory markers in patients with advanced renal cell carcinoma receiving nivolumab plus ipilimumab

Robot-assisted radical prostatectomy using the novel hinotoriTM surgical robot system: initial experience and operation learning curve at a single institution

Testicular seminoma in transverse testicular ectopia

Feasibility and outcomes of selective tetramodal bladder-preservation therapy in elderly patients with muscle-invasive bladder cancer

Female Gender Predicts Favorable Prognosis in Patients With Non-metastatic Clear Cell Renal Cell Carcinoma Undergoing Curative Surgery: Results From the International Marker Consortium for Renal Cancer (INMARC)

Application of virtual reality in patient explanation of magnetic resonance imaging–ultrasound fusion prostate biopsy

Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications

METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer

Postoperative renal impairment and longitudinal change in renal function after adrenalectomy in patients with Cushing's syndrome

Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non–muscle-invasive Bladder Cancer

Treatment-induced changes in levels of brain natriuretic peptide in prostate cancer patients receiving gonadotropin-releasing hormone antagonists or agonists

Collaborators (2)

Kouhei Nishikawa

Hajime Tanaka

Make your next move.